Spire Wealth Management Curis Inc Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$2.31 - $5.13 $924 - $2,052	-400 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$4.45 - $8.09 $1,780 - $3,236	400 New	400 $2,000
Q2 2021 Jul 26, 2021	SELL	$7.45 - $16.27 $2,980 - $6,508	-400 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$8.78 - $12.8 $3,511 - $5,120	400 New	400 $5,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.